A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Titel:
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Auteur:
Hari, Parameswaran Aljitawi, Omar S. Arce-Lara, Carlos Nath, Rajneesh Callander, Natalie Bhat, Gajanan Allen, Lee F. Stockerl-Goldstein, Keith
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 21 (2015) nr. 12 pagina's 6 p.
Jaar:
2015
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation